Page last updated: 2024-08-24

duloxetine hydrochloride and Arteriosclerosis, Coronary

duloxetine hydrochloride has been researched along with Arteriosclerosis, Coronary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drummer, OH; Gerostamoulos, D; Pilgrim, JL1
Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ1

Other Studies

2 other study(ies) available for duloxetine hydrochloride and Arteriosclerosis, Coronary

ArticleYear
The prevalence of duloxetine in medico-legal death investigations in Victoria, Australia (2009-2012).
    Forensic science international, 2014, Volume: 234

    Topics: Adult; Aged; Antidepressive Agents; Australia; Cardiomegaly; Cause of Death; Chromatography, Liquid; Cohort Studies; Coronary Artery Disease; Coroners and Medical Examiners; Drug Interactions; Duloxetine Hydrochloride; Female; Forensic Toxicology; Humans; Male; Middle Aged; Pharmaceutical Preparations; Prevalence; Pulmonary Edema; Tandem Mass Spectrometry; Thiophenes

2014
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
    Heart, lung & circulation, 2012, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride

2012